Clinical Trials Directory

Trials / Completed

CompletedNCT00936091

Effects of Vitamin A Supplementation on Intestinal Parasitic Reinfections

Effects of Vitamin A Supplementation on Intestinal Parasitic Reinfections, Growth, Iron Status and Educational Achievement Among Orang Asli Schoolchildren in Pos Betau, Pahang, Malaysia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
250 (actual)
Sponsor
Sana'a University · Academic / Other
Sex
All
Age
7 Years – 12 Years
Healthy volunteers
Accepted

Summary

Intestinal parasitic infections, malnutrition and iron deficiency anaemia (IDA) are still considered as public health problems in rural Malaysia especially among Orang Asli children. Despite intermittent control programmes, the prevalence of these problems is still high suggesting the need of other control and interventions measures. This randomized double-blind, placebo-controlled trial was carried out among Orang Asli schoolchildren from Sekolah Kebangsaan Betau in Pos Betau, Pahang (200 km northeast Kuala Lumpur) to investigate the effects of vitamin A supplementation on intestinal parasitic reinfections, growth, iron status and educational achievement. HYPOTHESES 1. Vitamin A supplementation has a negative effect on intestinal parasitic reinfections and the worm burden of infections among Orang Asli schoolchildren in Pos Betau, Kuala Lipis, Pahang. 2. Vitamin A supplementation has a positive effect on growth (weight and height) among Orang Asli schoolchildren. 3. Vitamin A supplementation is effective in improving serum iron status among Orang Asli schoolchildren. 4. Vitamin A supplementation has a positive effect on cognitive function and educational achievement among Orang Asli schoolchildren.

Detailed description

Children from Sekolah Kebangsaan Betau in Pos Betau, Kuala Lipis, Pahang served as the target population for this study. The selection criteria for study subjects were the following: * Age 7-12 years (according to birth date in birth certificate). * Non-menstruating females (age \<13) * No history or evidence of underlying haematological-related diseases such as thalassaemia and ovalocytosis. * No evidence of concomitant severe and/or chronic illness such as acute respiratory tract infections, mental retardation and neurological deficits. * Consent of parent to participate in the study.

Conditions

Interventions

TypeNameDescription
DRUGvitamin A supplementsgelatinous and reddish opaque capsules containing 200 000 IU vitamin A
DRUGPlacebo125 children received placebo capsules

Timeline

Start date
2007-05-01
Primary completion
2008-08-01
Completion
2008-08-01
First posted
2009-07-09
Last updated
2009-08-04

Locations

1 site across 1 country: Malaysia

Source: ClinicalTrials.gov record NCT00936091. Inclusion in this directory is not an endorsement.